Kraków, Poland

Pawel Guzik




Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Pawel Guzik: Innovator in Kinase Inhibitors**

Introduction

Pawel Guzik, an accomplished inventor based in Kraków, Poland, has made significant strides in the field of pharmaceuticals. With two patents to his name, his innovations focus on the development of benzimidazole derivatives that serve as kinase inhibitors, which hold promise for treating a variety of serious diseases.

Latest Patents

Guzik's latest patents revolve around the innovative derivatives of benzimidazoles. These compounds are designed as serine/threonine and tyrosine kinase inhibitors, specifically targeting PIM1-3 and DYRK1A kinases. The applications of these inventions are crucial, as they may be used in the treatment of diseases such as leukemias, lymphomas, solid tumors, and autoimmune disorders. His work presents a potential breakthrough in addressing the needs of patients suffering from these conditions.

Career Highlights

Pawel Guzik is associated with Selvita S.A., a cutting-edge company known for its research in drug discovery and development. His role within the company leverages his expertise in medicinal chemistry and pharmacology to advance innovative solutions that can significantly improve patient outcomes. Over the years, his dedication to research and development has positioned him as a leading figure in his field.

Collaborations

Throughout his career, Guzik has collaborated with talented professionals such as Wojciech Czardybon and Krzysztof Brzózka. These partnerships have fostered an environment of innovation and creativity, allowing for the exploration of new therapeutic avenues and the sharing of knowledge within the scientific community.

Conclusion

In summary, Pawel Guzik is a noteworthy inventor whose contributions to the field of kinase inhibitors are shaping the landscape of medical treatments. With his ongoing innovations at Selvita S.A. and collaborations with esteemed colleagues, Guzik is poised to make a lasting impact in the realm of pharmaceuticals, providing hope for those affected by various life-threatening diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…